Drugs company GSK has just been fined an astonishing $3 billion by regulators in the US for fraud which Deputy US Attorney General James Cole described as “unprecedented in both size and scope”. GSK marketed drugs for purposes for which they were unapproved, including to children, and failed to report adverse cardiovascular trial safety data. The [...]
